View : 266 Download: 0
Manufacturers' perceptions of the decision-making process for new drug reimbursement in South Korea
- Title
- Manufacturers' perceptions of the decision-making process for new drug reimbursement in South Korea
- Authors
- Son, Kyung-Bok; Park, Sylvia; You, Myoungsoon
- Ewha Authors
- 손경복
- SCOPUS Author ID
- 손경복
- Issue Date
- 2021
- Journal Title
- INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- ISSN
- 0266-4623
1471-6348
- Citation
- INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE vol. 37, no. 1
- Keywords
- Health technology assessment; New drug; Reimbursement decisions; Uncertainty; South Korea
- Publisher
- CAMBRIDGE UNIV PRESS
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- This study aimed to evaluate manufacturers' perceptions of the decision-making process for new drug reimbursement and to formulate implications in operating a health technology assessment system. In 2019, we conducted a questionnaire survey and a semistructured group interview for domestic (n = 6) and foreign manufacturers (n = 9) who had vast experience in introducing new medicines into the market through a health technology assessment. Representatives of manufacturers indicated that disease severity, budget impact, existence of alternative treatment, and health-related quality of life were relevant criteria when assessing reimbursement decisions. Compared with domestic manufacturers, foreign manufacturers were risk takers when making reimbursement decisions in terms of adopting a new drug and managing pharmaceutical expenditure. However, foreign manufacturers were risk-averse when evaluating new drugs with uncertainties based on real-world data such as clinical effectiveness. Based on manufacturers' perceptions of the decision-making process for new drug reimbursement, there is room for improvement in health technology assessment systems. Explaining the underlying reasons behind their decisions, unbiased participation by various stakeholders and their embedded roles in the decision-making process need to be emphasized. However, the measures suggested in this study should be introduced with cautions. The process of health technology assessment might be a target for those who undermine the system in pursuit of their private interests.
- DOI
- 10.1017/S0266462321000489
- Appears in Collections:
- 일반대학원 > 제약산업학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML